TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...
The clinical trial, known as the CDK4/6 Inhibitor Dosing Knowledge Study, is investigating personalized dosing strategies for ...
St. James Hospital unveiled a new bell in its cancer unit on Friday and a local cancer survivor volunteered to be the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback